Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    January 2019
  1. PARLATI L, Pol S
    HCV-infected dialysis patients: History is changing.
    Clin Res Hepatol Gastroenterol. 2019 Jan 4. pii: S2210-7401(18)30279.
    PubMed     Text format    


    December 2018
  2. CUNHA LRD, Vieira DA, Giampietro YG, Gomes AD, et al
    Interleukin-10 promoter gene polymorphisms are associated with the first major depressive episode in chronic hepatitis C patients.
    Clin Res Hepatol Gastroenterol. 2018 Dec 24. pii: S2210-7401(18)30276.
    PubMed     Text format     Abstract available


    October 2018
  3. ALBERTI A, Angarano G, Colombo M, Craxi A, et al
    Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience.
    Clin Res Hepatol Gastroenterol. 2018 Oct 27. pii: S2210-7401(18)30189.
    PubMed     Text format     Abstract available


  4. PARLATI L, Sirmai L, Dupuy CA, Glotz D, et al
    Evidence of HCV recovery after therapy of hepatitis C virus infection by direct acting antivirals.
    Clin Res Hepatol Gastroenterol. 2018 Oct 4. pii: S2210-7401(18)30183.
    PubMed     Text format    


    August 2018
  5. MEKKY MA, Abdel-Malek MO, Osman HA, Abdel-Aziz EM, et al
    Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease.
    Clin Res Hepatol Gastroenterol. 2018 Aug 27. pii: S2210-7401(18)30147.
    PubMed     Text format     Abstract available


    May 2018
  6. PAVONE P, Alfieri G, Corano-Scheri G, Pinacchio C, et al
    Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs).
    Clin Res Hepatol Gastroenterol. 2018 May 4. pii: S2210-7401(18)30038.
    PubMed     Text format    


    December 2017
  7. NAJAFI FARD S, Schietroma I, Corano Scheri G, Giustini N, et al
    Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
    Clin Res Hepatol Gastroenterol. 2017 Dec 23. pii: S2210-7401(17)30262.
    PubMed     Text format     Abstract available


    August 2017
  8. MAROT A, Belaid A, Orlent H, Serste T, et al
    Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.
    Clin Res Hepatol Gastroenterol. 2017 Aug 31. pii: S2210-7401(17)30134.
    PubMed     Text format     Abstract available


    July 2017
  9. ALI HEA, Abdel Hameed R, Effat H, Ahmed EK, et al
    Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017 Jul 24. pii: S2210-7401(17)30148.
    PubMed     Text format     Abstract available


    May 2017
  10. MASCIA C, Lichtner M, Zuccala P, Vita S, et al
    Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-gamma)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
    Clin Res Hepatol Gastroenterol. 2017 May 31. pii: S2210-7401(17)30098.
    PubMed     Text format     Abstract available


  11. ALGOUD M, Tissot-Dupont H, Menard A, Botta-Fridlund D, et al
    Spontaneous clearance of chronic hepatitis C virus infection in HIV-positive patients, southeastern France.
    Clin Res Hepatol Gastroenterol. 2017 May 16. pii: S2210-7401(17)30096.
    PubMed     Text format    


    April 2017
  12. TARAMASSO L, Ricci E, Celesia BM, Bonfanti P, et al
    Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?
    Clin Res Hepatol Gastroenterol. 2017 Apr 21. pii: S2210-7401(17)30085.
    PubMed     Text format    


    January 2017
  13. LIAO H, Tan P, Zhu Z, Yan X, et al
    Sofosbuvir in combination with daclatasvir in liver transplant recipients with HCV infection: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Jan 9. pii: S2210-7401(16)30207.
    PubMed     Text format     Abstract available


    November 2016
  14. BASSENDINE MF, Nielsen SU, Bridge SH, Felmlee DJ, et al
    Hepatitis C virus and atherosclerosis: A legacy after virologic cure?
    Clin Res Hepatol Gastroenterol. 2016 Nov 10. pii: S2210-7401(16)30138.
    PubMed     Text format     Abstract available


    April 2016
  15. QU Y, Li T, Wang L, Liu F, et al
    Efficacy and safety of simeprevir for chronic hepatitis virus C genotype 1 infection: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2016;40:203-12.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: